Customer Success Stories
Why a global biopharmaceutical leader switched to one unifying recruitment platform.
NUMBER OF EMPLOYEES:
iCIMS CLIENT SINCE:
Recruit, Connect, & Preboard
- Workday (HRIS)
- DocuSign (document management & analytics)
- CareerBuilder (background screening)
- Phenom People (candidate matching)
Founded in 2003, Jazz Pharmaceuticals develops life-changing medicines including therapies for blood disease and cancer. Headquartered in Dublin, Ireland, Jazz operates 12 offices throughout Europe and North America, and is one of the world's fastest growing companies, with plans to hire 350 additional employees in 2019 alone. Despite their growth and size, they rely on just four recruiters in the EU, seven in the U.S. and four sourcers to find and hire talent with elusive life sciences experience.
So, in 2017, after surpassing 1,000 employees, Jazz evaluated new recruiting solutions including People- Fluent, Jobvite, SAP, as well the recruiting module of their current HRIS solution, Workday. Jazz selected iCIMS as their long-term partner because of, as Alyson Nachman, senior HRIS analyst, explains the platform's scalability, stability and support.
To drive growth, Jazz needs to find the best qualified candidate no matter what country they are located. One of the determining factors in selecting iCIMS' suite of solutions is the ability to tailor and promote job posts by country within one single platform.
“We don’t know where we are going to hire somebody. We hire the best qualified candidate whether we find them in Philadelphia, Palo Alto or Germany, and with iCIMS we are able to target where the best candidate pool is.”
Alyson Nachman, senior HRIS analyst, Jazz Pharmaceuticals
Jazz selected and relies on iCIMS to recruit, manage their candidate experience and talent pools and onboard new employees.
"Having one system that has automated many of our processes that had been manual, has created an ability for the team to have more impact on their overall candidate and manager experience, because their time now is spent where it should be and not on the manual pieces of the process."